The Latest Cardiac and Vascular News
CAMPBELL, Calif.–(BUSINESS WIRE)–Simpson Interventions, Inc., a pioneering medical technology company, specializing in cardiovascular interventional devices, today announced achievement of major development milestones. Its truly unique Acolyte™ Image-Guided Crossing and Re-Entry Catheter System has been granted an Investigational Device Exemption by the U.S. Food and Drug Administration (FDA), after having been […]
AUSTIN, Texas–(BUSINESS WIRE)–Alleviant Medical, Inc., a privately held medical device company pioneering a no-implant atrial shunt for heart failure, today announced two significant milestones from the U.S. Food and Drug Administration (FDA). The FDA has granted the company investigational device exemption (IDE) approval to begin a pivotal trial focused on […]
SAN JOSE, Calif.–(BUSINESS WIRE)–Evident Vascular, Inc., a medical technology startup backed by Vensana Capital® developing an AI-powered next-generation intravascular ultrasound (IVUS) platform, is pleased to announce the appointment of Scott R. Ward to its Board of Directors. “We are thrilled to welcome Scott to the Evident Vascular Board” Post this […]
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, is pleased to announce the publication of a detailed review of its collaboration with U.S.-based Minnetronix, a world leader in high-precision medical device manufacturing. Published in the industry journal, Medical Design & Development, the article was co-authored by Tom Looby, Conavi Medical’s CEO and Darcy Hart, Minnetronix Medical’s Director of Optical Products.
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion. Inari, which was founded in 2011, will bring a leading peripheral vascular position in the fast-growing segment of venous thromboembolism (VTE) to Stryker. Inari’s innovative product portfolio is highly complementary to Stryker’s Neurovascular business and includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism.
Medtronic plc, a global leader in healthcare technology, today announced it received CE (Conformité Européenne) Mark for the Harmony™ Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). The Harmony TPV system […]
anuary 05, 2025 03:05 PM Eastern Standard Time GLASGOW, Scotland–(BUSINESS WIRE)–In what will be a worldwide wearables first, Novosound is set to demonstrate ultrasound blood pressure monitoring at CES 2025 in Las Vegas between 7th-10th January, with the company revealing how it has been able to achieve accuracy levels comparable to conventional electronic cuff […]
Seasoned MedTech Executive to Lead U.S. Launch of Vitestro’s Autonomous Robotic Blood-Draw Device UTRECHT, Netherlands, Jan. 6, 2025 /PRNewswire/ — Vitestro, a pioneer in autonomous robotic venous access and blood drawing, today announced the appointment of Bob Gerberich as Chief…
TORONTO, Jan. 6, 2025 /PRNewswire/ — Myant Corp., a leader in chronic disease prevention through precision medicine, announced the acquisition of mmHg Inc., a digital health company specializing in remote blood pressure monitoring, cardiovascular risk reduction, and chronic disease…
Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical ‘golden hour.’ SAN FRANCISCO, Jan. 6, 2025 /PRNewswire/ — Wellumio, a New…
